Inhibition of proteinase K activity by copper(II) ions

被引:21
作者
Stone, Lisa A.
Jackson, Graham S.
Collinge, John
Wadsworth, Jonathan D. F.
Clarke, Anthony R.
机构
[1] UCL, Inst Neurol, MRC Prion Univ, Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
[2] UCL, Inst Neurol, Dept Neurodegenerat Dis, Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
基金
英国医学研究理事会;
关键词
D O I
10.1021/bi061646s
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Disease-related prion protein, PrP(Sc), can be distinguished from its normal cellular precursor, PrP(C), by its detergent insolubility and partial resistance to proteolysis. Several studies have suggested that copper(II) ions can convert PrP(C) to a proteinase K-resistant conformation; however, interpretation of these studies is complicated by potential inhibition of proteinase K (PK) by copper(II) ions. Here we have examined directly the kinetic and equilibrium effects of copper(II) ions on PK activity using a simple synthetic substrate, p-nitrophenyl acetate. We show that at equilibrium two to three copper(II) ions bind stoichiometrically to PK and destroy its activity (K(d) < 1 mu M). This inhibition has two components, an initial reversible and weak binding phase and a slower, irreversible abolition of activity with a half-time of 6 min at saturating copper(II) ion concentrations. Copper(II) ions produce a similar biphasic inhibition of PK activity in the presence of brain homogenate but only when the copper(II) ion concentration exceeds that of the chelating components present in brain tissue. Under these conditions, the apparent resistance of PrP(C) to proteolysis by PK appears to be directly attributable to the inhibition of PK activity by copper(II) ions.
引用
收藏
页码:245 / 252
页数:8
相关论文
共 18 条
[1]   Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils [J].
Bocharova, OV ;
Breydo, L ;
Salnikov, VV ;
Baskakov, IV .
BIOCHEMISTRY, 2005, 44 (18) :6776-6787
[2]   Consequences of manganese replacement of copper for prion protein function and proteinase resistance [J].
Brown, DR ;
Hafiz, F ;
Glasssmith, LL ;
Wong, BS ;
Jones, IM ;
Clive, C ;
Haswell, SJ .
EMBO JOURNAL, 2000, 19 (06) :1180-1186
[3]   Prion diseases of humans and animals: Their causes and molecular basis [J].
Collinge, J .
ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 :519-550
[4]   SELF-REPLICATION AND SCRAPIE [J].
GRIFFITH, JS .
NATURE, 1967, 215 (5105) :1043-&
[5]   MOUSE POLYCLONAL AND MONOCLONAL-ANTIBODY TO SCRAPIE-ASSOCIATED FIBRIL PROTEINS [J].
KASCSAK, RJ ;
RUBENSTEIN, R ;
MERZ, PA ;
TONNADEMASI, M ;
FERSKO, R ;
CARP, RI ;
WISNIEWSKI, HM ;
DIRINGER, H .
JOURNAL OF VIROLOGY, 1987, 61 (12) :3688-3693
[6]   Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres [J].
Kim, NH ;
Choi, JK ;
Jeong, BH ;
Kim, JI ;
Kwon, MS ;
Carp, RI ;
Kim, YS .
FASEB JOURNAL, 2005, 19 (03) :783-+
[7]   Cellular prion protein acquires resistance to proteolytic degradation following copper ion binding [J].
Kuczius, T ;
Buschmann, A ;
Zhang, W ;
Karch, H ;
Becker, K ;
Peters, G ;
Groschup, MH .
BIOLOGICAL CHEMISTRY, 2004, 385 (08) :739-747
[8]   Reversibility of scrapie inactivation is enhanced by copper [J].
McKenzie, D ;
Bartz, J ;
Mirwald, J ;
Olander, D ;
Marsh, R ;
Aiken, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (40) :25545-25547
[9]  
MULLER A, 1994, J BIOL CHEM, V269, P23108
[10]  
MULLER A, 1993, J BIOL CHEM, V268, P26150